Research map: Oral vancomycin is not associated with meaningful changes in liver-related endpoints among adults with primary sclerosing cholangitis: A randomized, placebo-controlled trial

Back to the article

Papers in this map

  1. High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis # · Keith D. Lindor · 2009 · 727 citations · Cited by this paper
  2. Re: “Proximally dominant inflammation at colonoscopy predicts pan-colonic histological remission following oral vancomycin therapy in pediatric ulcerative colitis” · Dua Jabbar · 2026 · Cites this paper
  3. Dose May Matter: CYP2C19 Genotype and PPI Response in Pediatric Eosinophilic Esophagitis · 2026 · Related
  4. The 5-D itch scale: a new measure of pruritus · Scott Andrew Elman · 2009 · 544 citations · Cited by this paper
  5. Advances in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis · Sunny Sandhu · 2026 · Cites this paper
  6. What’s New in Rome V · 2026 · Related
  7. Pathogenesis of Primary Sclerosing Cholangitis and Advances in Diagnosis and Management · John E. Eaton · 2013 · 443 citations · Cited by this paper
  8. Response to Limberg and Imperiale · 2026 · Related
  9. AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma · Christopher L. Bowlus · 2022 · 423 citations · Cited by this paper
  10. Strategies for Gastroenterologists to Reduce the Burden of Early-Onset Colorectal Cancer Within Their Communities · 2026 · Related
  11. EASL Clinical Practice Guidelines on sclerosing cholangitis · Olivier Chazouillères · 2022 · 411 citations · Cited by this paper
  12. BEHÇET’S SYNDROME PRESENTING AS SEVERE ULCERATIVE ESOPHAGITIS: A DIAGNOSTIC CHALLENGE · 2026 · Related
  13. Baseline Values and Changes in Liver Stiffness Measured by Transient Elastography Are Associated With Severity of Fibrosis and Outcomes of Patients With Primary Sclerosing Cholangitis · Christophe Corpechot · 2014 · 298 citations · Cited by this paper
  14. Designing and Interpreting Large Database Studies in Gastroenterology and Hepatology · 2026 · Related
  15. Randomised clinical trial: vancomycin or metronidazole in patients with primary sclerosing cholangitis ‐ a pilot study · James H. Tabibian · 2013 · 272 citations · Cited by this paper
  16. Characteristics and outcomes of patients with imaging-defined MASLD and histological steatosis grade S0 · 2026 · Related
  17. Metronidazole and Ursodeoxycholic Acid for Primary Sclerosing Cholangitis: A Randomized Placebo–Controlled Trial · Martti A. Färkkilä · 2004 · 223 citations · Cited by this paper
  18. Disorders of Gut–Brain Interaction like symptoms in Children with Inflammatory Bowel Disease: A Multicenter Prospective Study from the Pediatric IBD Porto Group of the ESPGHAN. · 2026 · Related
  19. Improvement of serum alkaline phosphatase to <1.5 upper limit of normal predicts better outcome and reduced risk of cholangiocarcinoma in primary sclerosing cholangitis · Said Al Mamari · 2012 · 204 citations · Cited by this paper
  20. How I manage cirrhosis in a busy outpatient clinic? The P.O.R.T.A.L.V.E.I.N. mnemonic · 2026 · Related
  21. Simtuzumab for Primary Sclerosing Cholangitis: Phase 2 Study Results With Insights on the Natural History of the Disease · Andrew Joseph Muir · 2018 · 200 citations · Cited by this paper
  22. Association Between Reduced Levels of Alkaline Phosphatase and Survival Times of Patients With Primary Sclerosing Cholangitis · Lina Lindström · 2013 · 180 citations · Cited by this paper
  23. Long‐term Treatment of Primary Sclerosing Cholangitis in Children With Oral Vancomycin: An Immunomodulating Antibiotic · Yinka K. Davies · 2008 · 177 citations · Cited by this paper
  24. Alkaline phosphatase normalization is associated with better prognosis in primary sclerosing cholangitis · Peter P. Stanich · 2011 · 161 citations · Cited by this paper
  25. Minocycline in the Treatment of Patients With Primary Sclerosing Cholangitis: Results of a Pilot Study · Marina G. Silveira · 2008 · 129 citations · Cited by this paper
  26. Immunomodulatory Effect of Vancomycin on Treg in Pediatric Inflammatory Bowel Disease and Primary Sclerosing Cholangitis · David N. Abarbanel · 2012 · 119 citations · Cited by this paper
  27. The microbiota and the gut–liver axis in primary sclerosing cholangitis · Johannes R. Hov · 2022 · 115 citations · Cited by this paper
  28. A Triple Blinded, Randomized, Placebo-Controlled Clinical Trial to Evaluate the Efficacy and Safety of Oral Vancomycin in Primary Sclerosing Cholangitis: a Pilot Study · Shahab Rahimpour · 2016 · 113 citations · Cited by this paper
  29. Performance of magnetic resonance elastography in primary sclerosing cholangitis · John E. Eaton · 2015 · 107 citations · Cited by this paper
  30. Oral Vancomycin, Ursodeoxycholic Acid, or No Therapy for Pediatric Primary Sclerosing Cholangitis: A Matched Analysis · Mark R. Deneau · 2020 · 97 citations · Cited by this paper
  31. Simple Magnetic Resonance Scores Associate With Outcomes of Patients With Primary Sclerosing Cholangitis · Sara Lemoinne · 2019 · 76 citations · Cited by this paper
  32. Open-label prospective therapeutic clinical trials: oral vancomycin in children and adults with primary sclerosing cholangitis · Ahmad Hassan Ali · 2020 · 70 citations · Cited by this paper
  33. Severity strata for five patient-reported outcomes in adults with atopic dermatitis · Paras P. Vakharia · 2017 · 57 citations · Cited by this paper
  34. Inter- and Intra-individual Variation, and Limited Prognostic Utility, of Serum Alkaline Phosphatase in a Trial of Patients With Primary Sclerosing Cholangitis · Palak Jitendrakumar Trivedi · 2020 · 55 citations · Cited by this paper
  35. Changes in Liver Stiffness, Measured by Magnetic Resonance Elastography, Associated With Hepatic Decompensation in Patients With Primary Sclerosing Cholangitis · John E. Eaton · 2019 · 54 citations · Cited by this paper
  36. Development and validation of a primary sclerosing cholangitis–specific patient‐reported outcomes instrument · Zobair M. Younossi · 2017 · 49 citations · Cited by this paper
  37. Prospective evaluation of PBC ‐specific health‐related quality of life questionnaires in patients with primary sclerosing cholangitis · Joanna Raszeja‐Wyszomirska · 2014 · 43 citations · Cited by this paper
  38. An update on primary sclerosing cholangitis epidemiology, outcomes and quantification of alkaline phosphatase variability in a population-based cohort · Zeinab Bakhshi · 2020 · 42 citations · Cited by this paper
  39. Open Label Vancomycin in Primary Sclerosing Cholangitis-Inflammatory Bowel Disease: Improved Colonic Disease Activity and Associations With Changes in Host–Microbiome–Metabolomic Signatures · Mohammed Nabil Quraishi · 2024 · 37 citations · Cited by this paper

Source: OpenAlex (CC0)